LeállítvaFázis nélkül
Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis
A legfontosabb adatok
- Ki végzi
- Medtronic Spinal and Biologics
- Hol
- Rochester (Egyesült Államok)A helyszín megnézéseMég 2 másik országban, 3 helyszínen
- Azonosító
- Állapot
- Leállítva
- Résztvevők
- 10 fő vett részt
- Kezdés
- 2021. aug. 12.
- Befejezés
- 2026. jan. 14.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Braive™ Growth Modulation System (Braive™ GMS)
- A regiszteradat frissítve
- 2026. október 28.
- Miért állt le
- The decision to early terminate the study was taken based on the achievement of all primary endpoints at 24-month for every active subjects. In addition, there are currently no plans to use the collected data to seek regulatory approval.
Ki vehet részt
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 27 feltétel megnézéseKevesebb
Ki vehet részt
- A subject must meet all of the following inclusion criteria to participate in this study:
- Has a diagnosis of juvenile or adolescent idiopathic scoliosis
- Is skeletally immature with a Sanders Score of ≥2 to ≤5
- Has failed conservative care as per investigator's assessment
- Has a main thoracic Cobb angle between 30 and 60 degrees
- Has a Lenke Classification of 1A, 1B, or 1C
- Has kyphosis ≤ 40 degrees with a sagittal thoracic modifier N or negative
- Informed Consent Form/Assent and Authorization to Use and Disclose Health Information (if applicable) have been signed by Parent/legal guardian and/or patient/participant per local requirement
Ki nem vehet részt
- Has undergone previous spinal fusion procedure(s) at the affected levels
- Has had prior ipsilateral or contralateral chest surgery
- Concurrent participation in another clinical study that may add additional safety risks and/or confound study results
- Has an associated syndrome
- Has a history of malignant hyperthermia
- Has an active or significant risk of infection (immunocompromised)
- Has a suspected or documented allergy or intolerance to implant materials
- Has a major psychiatric disorder / history of drug abuse that would interfere with the subject's ability to comply with study instructions or might confound the study interpretation as per investigator's assessment (DSM-5 can be used as a reference)
- Has severe chronic lung disease (e.g., asthma, bronchiectasis)
- A subject will be excluded from participating in this study for any of the following reasons:
- Is pregnant or plans to become pregnant within the first 24-months of the study
- Has a curve that requires instrumentation below L1
- Has spinal MRI abnormalities (e.g., CHIARI malformation, Syrinx greater than 4mm, tethered cord)
- Has any type of non-idiopathic scoliosis
- Has a left-sided curve
- Has inadequate tissue coverage over the operative site as per investigator's assessment
- Is a ward of the court/state
- Has poor bone quality, as determined by the investigator, that may limit anterior fixation
- Is unwilling or unable to return for follow-up visits and/or follow intra-operative and/or postoperative instructions
Helyszínek itt: Egyesült Államok
Még 2 másik országban, 3 helyszínen
- Mayo ClinicRochester, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
The purpose of this study was to establish probable benefits and evaluate the safety and preliminary effectiveness of the Braive™ GMS when used in the treatment of pediatric progressive scoliosis.
A vizsgálat csoportja
- Braive™ Growth Modulation System (Braive™ GMS)A vizsgált kezelés
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Prospective, Multi-Center Study of the Braive™ Growth Modulation System When Used in the Treatment of Pediatric Patients Diagnosed With Juvenile or Adolescent Idiopathic Scoliosis
- A regiszteradat frissítve
- 2026. október 28.